Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial
Dysbiosis can be caused by a variety of pathogenic factors, such as inadequate dietary intake, use of antibiotics, psychological stress, and chronic diseases (16)
Peptides for injury recovery are gaining significant attention from the general public, especially as an alternative to prescription medicines, and BPC-157 stands out as a potential top choice for those dealing with stubborn, long-term injuries or ongoing digestive issues
Neurotrophic role of the next-generation probiotic strain L
Be thorough here
US$ 28.40
US$ 29.36
US$ 28.37
